Fabian D. Stoll
Hamburg, HH 20246, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tackling suboptimal clinical response after metabolic bariatric surgery: Impact of tirzepatide on weight loss and body composition.
Journal: Obesity research & clinical practice
Published: January 17, 2025
Sustained weight loss with semaglutide once weekly in patients without type 2 diabetes and post-bariatric treatment failure.
Journal: Clinical obesity
Published: January 14, 2023
Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery.
Journal: Obesity surgery
Published: September 25, 2022
CYP19A1 mediates severe SARS-CoV-2 disease outcome in males.
Journal: Cell reports. Medicine
Published: July 12, 2022
The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery-a Retrospective Analysis.
Journal: Obesity surgery
Published: April 24, 2022
NET Release of Long-Term Surviving Neutrophils.
Journal: Frontiers in immunology
Published: November 15, 2021
Thyroid-stimulating hormone levels in euthyroid patients 8 years following bariatric surgery.
Journal: International journal of obesity (2005)
Published: September 10, 2021
High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study.
Journal: Emerging microbes & infections
Published: August 17, 2021
Long-Term Improvement of Chronic Low-Grade Inflammation After Bariatric Surgery.
Journal: Obesity surgery
Published: December 07, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026